跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Koxib - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Koxib
Approved
STANDARD
Koxib
Lloyd Laboratories,Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d0e4e9fbf9950541
Company
Lloyd Laboratories,Inc.
Type
Standard
Approval Details
Approval Id
d0e4e9fbf9950541
Drug Approval Philippines Name
Koxib
Product Name
Koxib
Registration Number
DR-XY42540
Brand Name
Koxib
Generic Name
Celecoxib
Dosage Form
Capsule
Dosage Strength
200 mg
Manufacturer
Lloyd Laboratories,Inc.
Issuance Date
24 May 2023
Expiry Date
06 September 2028
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID) - selective COX-2 Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d0e4e9fbf9950541
Type
Standard
Back to Philippines FDA Approvals